InsidersTradesSigma
Follow the Metropolis Healthcare stock price and the full directors' dealings record of the company, a publicly traded company based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Market capitalisation: €120.9bn. The latest transaction was filed on 31 August 2026 (Disposal). Among the most active insiders: Duru Shah Family Trust & PACs. All data is accessible without an account.
Analysts rate Metropolis Healthcare Buy (bullish), based on 19 analysts. Average price target: ₹658.16.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Metropolis Healthcare is a company specializing in medical diagnostic services in India. It offers a wide range of laboratory tests and health services.